For research use only. Not for therapeutic Use.
Tisotumab vedotin is an antibody-drug conjugate (ADC) targeting tissue factor (TF). Tisotumab vedotin consists of a fully human monoclonal antibody to tissue factor (TF-011) conjugated to Monomethyl Auristatin E (MMAE). Tisotumab vedotin has good antitumor activity and can be used in the research of advanced or metastatic solid tumors[1].
| Catalog Number | I041181 |
| CAS Number | 1418731-10-8 |
| Purity | ≥95% |
| Reference | [1]. Markham A, et al. Tisotumab Vedotin: First Approval. Drugs. 2021 Dec;81(18):2141-2147. |
